Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,011 | 1,222 | 1,401 | 2,151 | 1,468 |
| Operating Income | -2,011 | -1,222 | -1,401 | -2,151 | -1,468 |
| Other Income | 97 | 103 | 126 | 135 | -5 |
| Pre-tax Income | -1,914 | -1,119 | -1,275 | -2,016 | -1,473 |
| Net Income Continuous | -1,914 | -1,119 | -1,275 | -2,016 | -1,473 |
| Net Income | $-1,914 | $-1,119 | $-1,275 | $-2,016 | $-1,473 |
| EPS Basic Total Ops | -2.31 | -1.65 | -2.10 | -2.20 | -3.43 |
| EPS Basic Continuous Ops | -2.31 | -1.65 | -2.10 | -2.75 | -2.83 |
| EPS Diluted Total Ops | -2.31 | -1.65 | -2.10 | -2.20 | -3.43 |
| EPS Diluted Continuous Ops | -2.31 | -1.65 | -2.10 | -2.75 | -2.83 |
| EPS Diluted Before Non-Recurring Items | -2.31 | 0.18 | -2.76 | -11.77 | N/A |
| EBITDA(a) | $-2,011 | $-1,154 | $-1,386 | $-2,145 | $-1,456 |